590
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Unresectability during open surgical exploration in planned cytoreductive surgery and hyperthermic intraperitoneal chemotherapy*

, , , , &
Pages 889-894 | Received 05 Jun 2016, Accepted 02 Aug 2016, Published online: 11 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Weining Wang, Grace Hwei Ching Tan, Claramae Shulyn Chia, Thakshayeni Skanthakumar, Khee Chee Soo & Melissa Ching Ching Teo. (2018) Are positron emission tomography-computed tomography (PET-CT) scans useful in preoperative assessment of patients with peritoneal disease before cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)?. International Journal of Hyperthermia 34:5, pages 524-531.
Read now
Paul H. Sugarbaker, Armando Sardi, Gina Brown, Clarisse Dromain, Pascal Rousset & James S. Jelinek. (2017) Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay. International Journal of Hyperthermia 33:5, pages 497-504.
Read now

Articles from other publishers (3)

Veronica Boldrin, Charif Khaled, Antoine El Asmar, Leonel Kamden, Francesco Sclafani, Maria Galdon Gomez, Michel Moreau, Michael Vouche & Gabriel Liberale. (2023) Predictive factors of non-completion of cytoreductive surgery in colorectal peritoneal metastasis. European Journal of Surgical Oncology, pages 107251.
Crossref
Paul H. Sugarbaker & David Chang. (2022) Peritoneal metastases from colorectal cancer in the absence of lymph node metastases show a high survival rate despite unfavorable prognostic indicators. European Journal of Surgical Oncology 48:7, pages 1619-1625.
Crossref
Zachary Zihui Yong, Grace Hwei Ching Tan, Nicholas Shannon, Claramae Chia & Melissa Ching Ching Teo. (2019) P.R.O.P.S. — A novel Pre-Operative Predictive Score for unresectability in patients with colorectal peritoneal metastases being considered for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). World Journal of Surgical Oncology 17:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.